Markets Edge

ReadingWhen PE allocators shift this decisively into healthcare, market structure follows. Smaller device manufacturers will see multiples compress as institutional capital stops hunting for them independently.

ReadingVertical integration in healthcare distribution now has institutional backing. Smaller infusion networks will face margin pressure as this deal closes and consolidation accelerates.

ReadingSecondary PE acquisitions indicate the easy exits are gone. Remaining portfolio companies need scale partners, not just capital partners.

ReadingSecondaries are moving from dark pools to lit venues. Watch which LP partnerships splinter as their GPs demand pricing opacity that interval funds no longer provide.

ReadingSecondaries buyers should expect increased seller sophistication and tighter bid processes over the next 18 months as institutional LPs professionalize their exits.

ReadingCrypto ETF flows are becoming a real-time sentiment index for institutional indecision. Directional conviction has fractured across three assets.

ReadingIndian exchange IPO appetite is real, but not at 2021 multiples. Market-structure plays still get marked at reality prices, not momentum prices.